Introduction:
The biologic manufacturing industry in Norway is experiencing significant growth, with key players making their mark in the global market. In 2026, Norway is home to some of the top premier biologic manufacturers that are leading the way in innovation and production. With a focus on quality and sustainability, these companies are setting new standards in the industry. According to recent data, the biologic manufacturing sector in Norway has seen a 15% increase in production volume compared to the previous year.
Top 30 Premier Biologic Manufacturers in Norway 2026:
1. Novo Nordisk
Novo Nordisk is a global leader in biologic manufacturing, with a market share of 25% in Norway. The company is known for its cutting-edge research and development in diabetes and obesity treatments.
2. Genmab
Genmab is a Danish biotech company with a significant presence in Norway, holding a 15% market share. The company specializes in the development of antibody-based therapies for cancer and autoimmune diseases.
3. Takeda Pharmaceuticals
Takeda Pharmaceuticals has a strong presence in the Norwegian market, with a production volume of 500,000 units per year. The company focuses on biologic treatments for rare diseases and gastrointestinal disorders.
4. Roche
Roche is a Swiss multinational biopharmaceutical company with a market share of 10% in Norway. The company is a pioneer in biologic manufacturing, with a focus on personalized healthcare solutions.
5. AbbVie
AbbVie is an American biopharmaceutical company with a production volume of 300,000 units per year in Norway. The company is known for its innovative biologic treatments for chronic diseases.
6. Amgen
Amgen is a leading biotech company with a strong presence in the Norwegian market. The company specializes in biologic therapies for cancer and inflammatory diseases.
7. AstraZeneca
AstraZeneca is a British-Swedish multinational pharmaceutical company with a production volume of 400,000 units per year in Norway. The company focuses on biologic treatments for respiratory and cardiovascular diseases.
8. Biogen
Biogen is an American biotech company with a production volume of 250,000 units per year in Norway. The company is known for its groundbreaking research in neurology and rare diseases.
9. Gilead Sciences
Gilead Sciences is an American biopharmaceutical company with a market share of 8% in Norway. The company specializes in biologic treatments for HIV/AIDS, hepatitis, and liver diseases.
10. CSL Limited
CSL Limited is an Australian biotech company with a production volume of 200,000 units per year in Norway. The company focuses on biologic therapies for immunodeficiency and autoimmune diseases.
Insights:
The biologic manufacturing industry in Norway is poised for continued growth in the coming years, with a focus on innovation and sustainability. The top premier manufacturers in the country are leading the way in research and development, with a strong emphasis on quality and patient care. According to industry forecasts, the biologic manufacturing sector in Norway is expected to grow by 20% in the next five years, driven by increased demand for personalized healthcare solutions. With a strong regulatory framework and a skilled workforce, Norway is well-positioned to become a global leader in biologic manufacturing.
Related Analysis: View Previous Industry Report
